biotech / news / / The News International
J&J is using artificial intelligence to generate new leads for developing drugs.
Johnson & Johnson uses AI to cut drug lead optimization time by 50%.
KEY POINTS
- AI reduced the preparation time for clinical trial reports from 700 hours to about 15 minutes.
- J&J is using AI to analyze and identify promising chemical compounds or biologics for drug development.
- AI assists J&J manufacturing by optimizing solvent addition timing and temperature in production processes.
COMPANIES
Summarized by Newsio from The News International. How we summarize →